Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Zenas BioPharma, Inc.ZBIO · Entity 275 | See Remarks | June 15, 2026 | June 17, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Zenas BioPharma, Inc.
Report date June 15, 2026 · Filed June 17, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 974 |
Reported balance
After 2026-02-05 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2026-02-05 · Grant · Acquired 974 · Balance 974 F1: Common Stock acquired under Zenas BioPharma, Inc.'s 2024 Employee Stock Purchase Plan on February 5, 2026 in transactions that were exempt under Rule 16b-3(c). |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $18.71 · Expires 2036-06-15 | Direct | 175,000 |
Reported balance
After 2026-06-15 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2026-06-15 · Grant · Acquired 175,000 · Balance 175,000 F2: The option vests as to 25% of the underlying shares of common stock on June 15, 2027, the first anniversary of the vesting commencement date, and as to the remaining shares, in equal monthly installments over 36 months thereafter, subject to continued service. |
Filing footnotes · ownership attribution and instrument terms
F1: Common Stock acquired under Zenas BioPharma, Inc.'s 2024 Employee Stock Purchase Plan on February 5, 2026 in transactions that were exempt under Rule 16b-3(c).
F2: The option vests as to 25% of the underlying shares of common stock on June 15, 2027, the first anniversary of the vesting commencement date, and as to the remaining shares, in equal monthly installments over 36 months thereafter, subject to continued service.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
TESARO, Inc.
Report date January 22, 2019 · Filed January 22, 2019
Section 16 reporting ended · disclosed 2019-01-22. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2019-01-22 transaction · row 1
1 source rowRow 1 · 2019-01-22 · Other · Disposed 9,367 · Balance 0 F1: Tendered in connection with the tender offer made by Adriatic Acquisition Corporation, a Delaware corporation ("Purchaser") and a wholly-owned subsidiary of GlaxoSmithKline plc, a public company organized under the laws of England and Wales ("Parent"), to purchase all of the issued and outstanding shares of TESARO, Inc., a Delaware corporation ("TESARO"), for $75.00 per share, pursuant to the terms of that certain Agreement and Plan of Merger, dated as of December 3, 2018 by and among TESARO, Purchaser, and Parent (the "Merger Agreement"). F2: This number includes shares of TESARO common stock purchased under the TESARO, Inc. 2012 Employee Stock Purchase Plan. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2019-01-22 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2019-01-22 · Disposition to issuer · Disposed 8,750 · Balance 0 F3: Each restricted stock unit represents a contingent right to receive one share of TESARO common stock. F4: These restricted stock units were cancelled pursuant to the Merger Agreement at the effective time of the Merger (the "Effective Time") in exchange for a cash payment of $75.00 per share. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2019-01-22 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2019-01-22 · Disposition to issuer · Disposed 1,250 · Balance 0 F3: Each restricted stock unit represents a contingent right to receive one share of TESARO common stock. F4: These restricted stock units were cancelled pursuant to the Merger Agreement at the effective time of the Merger (the "Effective Time") in exchange for a cash payment of $75.00 per share. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2019-01-22 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2019-01-22 · Disposition to issuer · Disposed 4,447 · Balance 0 F3: Each restricted stock unit represents a contingent right to receive one share of TESARO common stock. F4: These restricted stock units were cancelled pursuant to the Merger Agreement at the effective time of the Merger (the "Effective Time") in exchange for a cash payment of $75.00 per share. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2019-01-22 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2019-01-22 · Disposition to issuer · Disposed 18,182 · Balance 0 F3: Each restricted stock unit represents a contingent right to receive one share of TESARO common stock. F4: These restricted stock units were cancelled pursuant to the Merger Agreement at the effective time of the Merger (the "Effective Time") in exchange for a cash payment of $75.00 per share. |
| Employee Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $57.66 · Expires 2025-03-30 | Direct | 0 |
Reported balance
After 2019-01-22 transaction · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · 2019-01-22 · Disposition to issuer · Disposed 75,000 · Balance 0 F5: Pursuant to the Merger Agreement, each option that was outstanding and unvested immediately prior to the Effective Time vested in full at the Effective Time. [Cont'd] F6: [Continuation] Each option that was outstanding immediately prior to the Effective Time that had an exercise price per share less than $75.00 was cancelled in exchange for the right of the holder to receive (without interest) an amount in cash (less applicable withholding of taxes required by applicable law) equal to the product of (i) the total number of shares of TESARO common stock subject to the unexercised portion of such option immediately prior to the Effective Time (determined after giving effect to the accelerated vesting described in the previous sentence) multiplied by (ii) the excess, if any, of $75.00 over the applicable exercise price per share under such option. Each option that was outstanding immediately prior to the Effective Time with an exercise price per share that is greater than or equal to $75.00 was cancelled at the Effective Time, and the holder of such option is not entitled to any payment in exchange for the cancellation of the option. |
| Employee Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $43.39 · Expires 2026-03-01 | Direct | 0 |
Reported balance
After 2019-01-22 transaction · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · 2019-01-22 · Disposition to issuer · Disposed 35,000 · Balance 0 F5: Pursuant to the Merger Agreement, each option that was outstanding and unvested immediately prior to the Effective Time vested in full at the Effective Time. [Cont'd] F6: [Continuation] Each option that was outstanding immediately prior to the Effective Time that had an exercise price per share less than $75.00 was cancelled in exchange for the right of the holder to receive (without interest) an amount in cash (less applicable withholding of taxes required by applicable law) equal to the product of (i) the total number of shares of TESARO common stock subject to the unexercised portion of such option immediately prior to the Effective Time (determined after giving effect to the accelerated vesting described in the previous sentence) multiplied by (ii) the excess, if any, of $75.00 over the applicable exercise price per share under such option. Each option that was outstanding immediately prior to the Effective Time with an exercise price per share that is greater than or equal to $75.00 was cancelled at the Effective Time, and the holder of such option is not entitled to any payment in exchange for the cancellation of the option. |
| Employee Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $178.95 · Expires 2027-03-01 | Direct | 0 |
Reported balance
After 2019-01-22 transaction · row 8
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 8 · 2019-01-22 · Disposition to issuer · Disposed 10,782 · Balance 0 F5: Pursuant to the Merger Agreement, each option that was outstanding and unvested immediately prior to the Effective Time vested in full at the Effective Time. [Cont'd] F6: [Continuation] Each option that was outstanding immediately prior to the Effective Time that had an exercise price per share less than $75.00 was cancelled in exchange for the right of the holder to receive (without interest) an amount in cash (less applicable withholding of taxes required by applicable law) equal to the product of (i) the total number of shares of TESARO common stock subject to the unexercised portion of such option immediately prior to the Effective Time (determined after giving effect to the accelerated vesting described in the previous sentence) multiplied by (ii) the excess, if any, of $75.00 over the applicable exercise price per share under such option. Each option that was outstanding immediately prior to the Effective Time with an exercise price per share that is greater than or equal to $75.00 was cancelled at the Effective Time, and the holder of such option is not entitled to any payment in exchange for the cancellation of the option. |
| Employee Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $55.84 · Expires 2028-03-01 | Direct | 0 |
Reported balance
After 2019-01-22 transaction · row 9
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 9 · 2019-01-22 · Disposition to issuer · Disposed 31,954 · Balance 0 F5: Pursuant to the Merger Agreement, each option that was outstanding and unvested immediately prior to the Effective Time vested in full at the Effective Time. [Cont'd] F6: [Continuation] Each option that was outstanding immediately prior to the Effective Time that had an exercise price per share less than $75.00 was cancelled in exchange for the right of the holder to receive (without interest) an amount in cash (less applicable withholding of taxes required by applicable law) equal to the product of (i) the total number of shares of TESARO common stock subject to the unexercised portion of such option immediately prior to the Effective Time (determined after giving effect to the accelerated vesting described in the previous sentence) multiplied by (ii) the excess, if any, of $75.00 over the applicable exercise price per share under such option. Each option that was outstanding immediately prior to the Effective Time with an exercise price per share that is greater than or equal to $75.00 was cancelled at the Effective Time, and the holder of such option is not entitled to any payment in exchange for the cancellation of the option. |
Filing footnotes · ownership attribution and instrument terms
F1: Tendered in connection with the tender offer made by Adriatic Acquisition Corporation, a Delaware corporation ("Purchaser") and a wholly-owned subsidiary of GlaxoSmithKline plc, a public company organized under the laws of England and Wales ("Parent"), to purchase all of the issued and outstanding shares of TESARO, Inc., a Delaware corporation ("TESARO"), for $75.00 per share, pursuant to the terms of that certain Agreement and Plan of Merger, dated as of December 3, 2018 by and among TESARO, Purchaser, and Parent (the "Merger Agreement").
F2: This number includes shares of TESARO common stock purchased under the TESARO, Inc. 2012 Employee Stock Purchase Plan.
F3: Each restricted stock unit represents a contingent right to receive one share of TESARO common stock.
F4: These restricted stock units were cancelled pursuant to the Merger Agreement at the effective time of the Merger (the "Effective Time") in exchange for a cash payment of $75.00 per share.
F5: Pursuant to the Merger Agreement, each option that was outstanding and unvested immediately prior to the Effective Time vested in full at the Effective Time. [Cont'd]
F6: [Continuation] Each option that was outstanding immediately prior to the Effective Time that had an exercise price per share less than $75.00 was cancelled in exchange for the right of the holder to receive (without interest) an amount in cash (less applicable withholding of taxes required by applicable law) equal to the product of (i) the total number of shares of TESARO common stock subject to the unexercised portion of such option immediately prior to the Effective Time (determined after giving effect to the accelerated vesting described in the previous sentence) multiplied by (ii) the excess, if any, of $75.00 over the applicable exercise price per share under such option. Each option that was outstanding immediately prior to the Effective Time with an exercise price per share that is greater than or equal to $75.00 was cancelled at the Effective Time, and the holder of such option is not entitled to any payment in exchange for the cancellation of the option.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 15, 2026 Filed Jun 17, 2026 22:00 UTC | Zenas BioPharma, Inc. ZBIO · Entity 275 | GrantStock Option (Right to Buy) · Derivative | 175,000 | $0.00 Strike: $18.71 | $0.00 |
DisclosureSEC source: 0001104659-26-075250 · tm2618042-2_4seq1.xml · derivative · entry 2 Farmer Joseph L · CIK 0001317757 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 175,000 Underlying: Common Stock · 175,000 shares Expires 2036-06-15 F2 · derivative.exercise_date: The option vests as to 25% of the underlying shares of common stock on June 15, 2027, the first anniversary of the vesting commencement date, and as to the remaining shares, in equal monthly installments over 36 months thereafter, subject to continued service. Read SEC document |
| February 05, 2026 Filed Jun 17, 2026 22:00 UTC | Zenas BioPharma, Inc. ZBIO · Entity 275 | GrantCommon Stock | 974 | $13.35 | $13,002.90 |
DisclosureSEC source: 0001104659-26-075250 · tm2618042-2_4seq1.xml · nonDerivative · entry 1 Farmer Joseph L · CIK 0001317757 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 974 F1 · balance_after: Common Stock acquired under Zenas BioPharma, Inc.'s 2024 Employee Stock Purchase Plan on February 5, 2026 in transactions that were exempt under Rule 16b-3(c). Read SEC document |
| June 10, 2025 Filed Jun 12, 2025 20:35 UTC | Zenas BioPharma, Inc. ZBIO · Entity 275 | GrantStock Option (Right to Buy) · Derivative | 175,000 | $0.00 Strike: $11.94 | $0.00 |
DisclosureSEC source: 0001104659-25-058930 · tm2517684-6_4seq1.xml · derivative · entry 1 Farmer Joseph L · CIK 0001317757 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 175,000 Underlying: Common Stock · 175,000 shares Expires 2035-06-10 F1 · derivative.exercise_date: The option vests as to 25% of the underlying shares of common stock on June 10, 2026, the first anniversary of the vesting commencement date, and as to the remaining shares, in equal month installments over 36 months thereafter, subject to continued service. Read SEC document |
| September 12, 2024 Filed Sep 17, 2024 00:50 UTC | Zenas BioPharma, Inc. ZBIO · Entity 275 | GrantStock Option (Right to Buy) · Derivative | 206,000 | $0.00 Strike: $17.00 | $0.00 |
DisclosureSEC source: 0001104659-24-100327 · tm2424157-6_4seq1.xml · derivative · entry 1 Farmer Joseph L · CIK 0001317757 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 206,000 Underlying: Common Stock · 206,000 shares Expires 2034-09-11 F1 · derivative.exercise_date: The option vests as to 25% of the underlying shares of common stock on September 12, 2025, the first anniversary of the vesting commencement date, and as to the remaining shares, in equal month installments over 36 months thereafter, subject to continued service. Read SEC document |
| January 22, 2019 Filed Jan 22, 2019 09:56 UTC | TESARO, Inc. TSRO · Entity 160894 | Disposition to issuerEmployee Stock Option (right to buy) · Derivative | 31,954 | Not disclosed Strike: $55.84 | Not disclosed |
DisclosureSEC source: 0001123292-19-000166 · edgar.xml · derivative · entry 9 Farmer Joseph L · CIK 0001317757 · Sr VP, Gen Counsel & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 31,954 shares Expires 2028-03-01 F5 · price: Pursuant to the Merger Agreement, each option that was outstanding and unvested immediately prior to the Effective Time vested in full at the Effective Time. [Cont'd] F6 · price: [Continuation] Each option that was outstanding immediately prior to the Effective Time that had an exercise price per share less than $75.00 was cancelled in exchange for the right of the holder to receive (without interest) an amount in cash (less applicable withholding of taxes required by applicable law) equal to the product of (i) the total number of shares of TESARO common stock subject to the unexercised portion of such option immediately prior to the Effective Time (determined after giving effect to the accelerated vesting described in the previous sentence) multiplied by (ii) the excess, if any, of $75.00 over the applicable exercise price per share under such option. Each option that was outstanding immediately prior to the Effective Time with an exercise price per share that is greater than or equal to $75.00 was cancelled at the Effective Time, and the holder of such option is not entitled to any payment in exchange for the cancellation of the option. F5 · derivative.exercise_date: Pursuant to the Merger Agreement, each option that was outstanding and unvested immediately prior to the Effective Time vested in full at the Effective Time. [Cont'd] F6 · derivative.exercise_date: [Continuation] Each option that was outstanding immediately prior to the Effective Time that had an exercise price per share less than $75.00 was cancelled in exchange for the right of the holder to receive (without interest) an amount in cash (less applicable withholding of taxes required by applicable law) equal to the product of (i) the total number of shares of TESARO common stock subject to the unexercised portion of such option immediately prior to the Effective Time (determined after giving effect to the accelerated vesting described in the previous sentence) multiplied by (ii) the excess, if any, of $75.00 over the applicable exercise price per share under such option. Each option that was outstanding immediately prior to the Effective Time with an exercise price per share that is greater than or equal to $75.00 was cancelled at the Effective Time, and the holder of such option is not entitled to any payment in exchange for the cancellation of the option. Read SEC document |
| January 22, 2019 Filed Jan 22, 2019 09:56 UTC | TESARO, Inc. TSRO · Entity 160894 | Disposition to issuerEmployee Stock Option (right to buy) · Derivative | 10,782 | Not disclosed Strike: $178.95 | Not disclosed |
DisclosureSEC source: 0001123292-19-000166 · edgar.xml · derivative · entry 8 Farmer Joseph L · CIK 0001317757 · Sr VP, Gen Counsel & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 10,782 shares Expires 2027-03-01 F5 · price: Pursuant to the Merger Agreement, each option that was outstanding and unvested immediately prior to the Effective Time vested in full at the Effective Time. [Cont'd] F6 · price: [Continuation] Each option that was outstanding immediately prior to the Effective Time that had an exercise price per share less than $75.00 was cancelled in exchange for the right of the holder to receive (without interest) an amount in cash (less applicable withholding of taxes required by applicable law) equal to the product of (i) the total number of shares of TESARO common stock subject to the unexercised portion of such option immediately prior to the Effective Time (determined after giving effect to the accelerated vesting described in the previous sentence) multiplied by (ii) the excess, if any, of $75.00 over the applicable exercise price per share under such option. Each option that was outstanding immediately prior to the Effective Time with an exercise price per share that is greater than or equal to $75.00 was cancelled at the Effective Time, and the holder of such option is not entitled to any payment in exchange for the cancellation of the option. F5 · derivative.exercise_date: Pursuant to the Merger Agreement, each option that was outstanding and unvested immediately prior to the Effective Time vested in full at the Effective Time. [Cont'd] F6 · derivative.exercise_date: [Continuation] Each option that was outstanding immediately prior to the Effective Time that had an exercise price per share less than $75.00 was cancelled in exchange for the right of the holder to receive (without interest) an amount in cash (less applicable withholding of taxes required by applicable law) equal to the product of (i) the total number of shares of TESARO common stock subject to the unexercised portion of such option immediately prior to the Effective Time (determined after giving effect to the accelerated vesting described in the previous sentence) multiplied by (ii) the excess, if any, of $75.00 over the applicable exercise price per share under such option. Each option that was outstanding immediately prior to the Effective Time with an exercise price per share that is greater than or equal to $75.00 was cancelled at the Effective Time, and the holder of such option is not entitled to any payment in exchange for the cancellation of the option. Read SEC document |
| January 22, 2019 Filed Jan 22, 2019 09:56 UTC | TESARO, Inc. TSRO · Entity 160894 | Disposition to issuerEmployee Stock Option (right to buy) · Derivative | 35,000 | Not disclosed Strike: $43.39 | Not disclosed |
DisclosureSEC source: 0001123292-19-000166 · edgar.xml · derivative · entry 7 Farmer Joseph L · CIK 0001317757 · Sr VP, Gen Counsel & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 35,000 shares Expires 2026-03-01 F5 · price: Pursuant to the Merger Agreement, each option that was outstanding and unvested immediately prior to the Effective Time vested in full at the Effective Time. [Cont'd] F6 · price: [Continuation] Each option that was outstanding immediately prior to the Effective Time that had an exercise price per share less than $75.00 was cancelled in exchange for the right of the holder to receive (without interest) an amount in cash (less applicable withholding of taxes required by applicable law) equal to the product of (i) the total number of shares of TESARO common stock subject to the unexercised portion of such option immediately prior to the Effective Time (determined after giving effect to the accelerated vesting described in the previous sentence) multiplied by (ii) the excess, if any, of $75.00 over the applicable exercise price per share under such option. Each option that was outstanding immediately prior to the Effective Time with an exercise price per share that is greater than or equal to $75.00 was cancelled at the Effective Time, and the holder of such option is not entitled to any payment in exchange for the cancellation of the option. F5 · derivative.exercise_date: Pursuant to the Merger Agreement, each option that was outstanding and unvested immediately prior to the Effective Time vested in full at the Effective Time. [Cont'd] F6 · derivative.exercise_date: [Continuation] Each option that was outstanding immediately prior to the Effective Time that had an exercise price per share less than $75.00 was cancelled in exchange for the right of the holder to receive (without interest) an amount in cash (less applicable withholding of taxes required by applicable law) equal to the product of (i) the total number of shares of TESARO common stock subject to the unexercised portion of such option immediately prior to the Effective Time (determined after giving effect to the accelerated vesting described in the previous sentence) multiplied by (ii) the excess, if any, of $75.00 over the applicable exercise price per share under such option. Each option that was outstanding immediately prior to the Effective Time with an exercise price per share that is greater than or equal to $75.00 was cancelled at the Effective Time, and the holder of such option is not entitled to any payment in exchange for the cancellation of the option. Read SEC document |
| January 22, 2019 Filed Jan 22, 2019 09:56 UTC | TESARO, Inc. TSRO · Entity 160894 | Disposition to issuerEmployee Stock Option (right to buy) · Derivative | 75,000 | Not disclosed Strike: $57.66 | Not disclosed |
DisclosureSEC source: 0001123292-19-000166 · edgar.xml · derivative · entry 6 Farmer Joseph L · CIK 0001317757 · Sr VP, Gen Counsel & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 75,000 shares Expires 2025-03-30 F5 · price: Pursuant to the Merger Agreement, each option that was outstanding and unvested immediately prior to the Effective Time vested in full at the Effective Time. [Cont'd] F6 · price: [Continuation] Each option that was outstanding immediately prior to the Effective Time that had an exercise price per share less than $75.00 was cancelled in exchange for the right of the holder to receive (without interest) an amount in cash (less applicable withholding of taxes required by applicable law) equal to the product of (i) the total number of shares of TESARO common stock subject to the unexercised portion of such option immediately prior to the Effective Time (determined after giving effect to the accelerated vesting described in the previous sentence) multiplied by (ii) the excess, if any, of $75.00 over the applicable exercise price per share under such option. Each option that was outstanding immediately prior to the Effective Time with an exercise price per share that is greater than or equal to $75.00 was cancelled at the Effective Time, and the holder of such option is not entitled to any payment in exchange for the cancellation of the option. F5 · derivative.exercise_date: Pursuant to the Merger Agreement, each option that was outstanding and unvested immediately prior to the Effective Time vested in full at the Effective Time. [Cont'd] F6 · derivative.exercise_date: [Continuation] Each option that was outstanding immediately prior to the Effective Time that had an exercise price per share less than $75.00 was cancelled in exchange for the right of the holder to receive (without interest) an amount in cash (less applicable withholding of taxes required by applicable law) equal to the product of (i) the total number of shares of TESARO common stock subject to the unexercised portion of such option immediately prior to the Effective Time (determined after giving effect to the accelerated vesting described in the previous sentence) multiplied by (ii) the excess, if any, of $75.00 over the applicable exercise price per share under such option. Each option that was outstanding immediately prior to the Effective Time with an exercise price per share that is greater than or equal to $75.00 was cancelled at the Effective Time, and the holder of such option is not entitled to any payment in exchange for the cancellation of the option. Read SEC document |
| January 22, 2019 Filed Jan 22, 2019 09:56 UTC | TESARO, Inc. TSRO · Entity 160894 | Disposition to issuerRestricted Stock Units · Derivative | 18,182 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001123292-19-000166 · edgar.xml · derivative · entry 5 Farmer Joseph L · CIK 0001317757 · Sr VP, Gen Counsel & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 18,182 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of TESARO common stock. F4 · price: These restricted stock units were cancelled pursuant to the Merger Agreement at the effective time of the Merger (the "Effective Time") in exchange for a cash payment of $75.00 per share. F4 · derivative.exercise_date: These restricted stock units were cancelled pursuant to the Merger Agreement at the effective time of the Merger (the "Effective Time") in exchange for a cash payment of $75.00 per share. F4 · derivative.expiration_date: These restricted stock units were cancelled pursuant to the Merger Agreement at the effective time of the Merger (the "Effective Time") in exchange for a cash payment of $75.00 per share. Read SEC document |
| January 22, 2019 Filed Jan 22, 2019 09:56 UTC | TESARO, Inc. TSRO · Entity 160894 | Disposition to issuerRestricted Stock Units · Derivative | 4,447 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001123292-19-000166 · edgar.xml · derivative · entry 4 Farmer Joseph L · CIK 0001317757 · Sr VP, Gen Counsel & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,447 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of TESARO common stock. F4 · price: These restricted stock units were cancelled pursuant to the Merger Agreement at the effective time of the Merger (the "Effective Time") in exchange for a cash payment of $75.00 per share. F4 · derivative.exercise_date: These restricted stock units were cancelled pursuant to the Merger Agreement at the effective time of the Merger (the "Effective Time") in exchange for a cash payment of $75.00 per share. F4 · derivative.expiration_date: These restricted stock units were cancelled pursuant to the Merger Agreement at the effective time of the Merger (the "Effective Time") in exchange for a cash payment of $75.00 per share. Read SEC document |
| January 22, 2019 Filed Jan 22, 2019 09:56 UTC | TESARO, Inc. TSRO · Entity 160894 | Disposition to issuerRestricted Stock Units · Derivative | 1,250 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001123292-19-000166 · edgar.xml · derivative · entry 3 Farmer Joseph L · CIK 0001317757 · Sr VP, Gen Counsel & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,250 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of TESARO common stock. F4 · price: These restricted stock units were cancelled pursuant to the Merger Agreement at the effective time of the Merger (the "Effective Time") in exchange for a cash payment of $75.00 per share. F4 · derivative.exercise_date: These restricted stock units were cancelled pursuant to the Merger Agreement at the effective time of the Merger (the "Effective Time") in exchange for a cash payment of $75.00 per share. F4 · derivative.expiration_date: These restricted stock units were cancelled pursuant to the Merger Agreement at the effective time of the Merger (the "Effective Time") in exchange for a cash payment of $75.00 per share. Read SEC document |
| January 22, 2019 Filed Jan 22, 2019 09:56 UTC | TESARO, Inc. TSRO · Entity 160894 | Disposition to issuerRestricted Stock Units · Derivative | 8,750 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001123292-19-000166 · edgar.xml · derivative · entry 2 Farmer Joseph L · CIK 0001317757 · Sr VP, Gen Counsel & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 8,750 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of TESARO common stock. F4 · price: These restricted stock units were cancelled pursuant to the Merger Agreement at the effective time of the Merger (the "Effective Time") in exchange for a cash payment of $75.00 per share. F4 · derivative.exercise_date: These restricted stock units were cancelled pursuant to the Merger Agreement at the effective time of the Merger (the "Effective Time") in exchange for a cash payment of $75.00 per share. F4 · derivative.expiration_date: These restricted stock units were cancelled pursuant to the Merger Agreement at the effective time of the Merger (the "Effective Time") in exchange for a cash payment of $75.00 per share. Read SEC document |
| January 22, 2019 Filed Jan 22, 2019 09:56 UTC | TESARO, Inc. TSRO · Entity 160894 | OtherCommon Stock | 9,367 | $75.00 | $702,525.00 |
DisclosureSEC source: 0001123292-19-000166 · edgar.xml · nonDerivative · entry 1 Farmer Joseph L · CIK 0001317757 · Sr VP, Gen Counsel & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · shares: Tendered in connection with the tender offer made by Adriatic Acquisition Corporation, a Delaware corporation ("Purchaser") and a wholly-owned subsidiary of GlaxoSmithKline plc, a public company organized under the laws of England and Wales ("Parent"), to purchase all of the issued and outstanding shares of TESARO, Inc., a Delaware corporation ("TESARO"), for $75.00 per share, pursuant to the terms of that certain Agreement and Plan of Merger, dated as of December 3, 2018 by and among TESARO, Purchaser, and Parent (the "Merger Agreement"). F2 · shares: This number includes shares of TESARO common stock purchased under the TESARO, Inc. 2012 Employee Stock Purchase Plan. Read SEC document |
| August 01, 2018 Filed Aug 3, 2018 17:00 UTC | TESARO, Inc. TSRO · Entity 160894 | Exercise / conversionRestricted Stock Units · Derivative | 625 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-18-049533 · a4.xml · derivative · entry 3 Farmer Joseph L · CIK 0001317757 · Sr VP, Gen Counsel & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,250 Underlying: Common Stock · 625 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of TESARO common stock. F3 · derivative.exercise_date: The restricted stock units were granted on July 27, 2016 and vest in four equal installments beginning on August 1, 2017. F3 · derivative.expiration_date: The restricted stock units were granted on July 27, 2016 and vest in four equal installments beginning on August 1, 2017. Read SEC document |
| August 01, 2018 Filed Aug 3, 2018 17:00 UTC | TESARO, Inc. TSRO · Entity 160894 | SaleCommon Stock | 187 | $34.37 | $6,427.19 |
DisclosureSEC source: 0001104659-18-049533 · a4.xml · nonDerivative · entry 2 Farmer Joseph L · CIK 0001317757 · Sr VP, Gen Counsel & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,292 F1 · kind: This sale was effected in accordance with the terms of the underlying restricted stock unit award agreement, and a 10b5-1 trading plan entered into by the reporting person, and was made in order to pay tax liability arising from the vesting of the restricted stock units. Read SEC document |
| August 01, 2018 Filed Aug 3, 2018 17:00 UTC | TESARO, Inc. TSRO · Entity 160894 | Exercise / conversionCommon Stock | 625 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-18-049533 · a4.xml · nonDerivative · entry 1 Farmer Joseph L · CIK 0001317757 · Sr VP, Gen Counsel & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,479 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 02, 2018 Filed Mar 5, 2018 17:26 UTC | TESARO, Inc. TSRO · Entity 160894 | SaleCommon Stock | 2,634 | $54.86 | $144,501.24 |
DisclosureSEC source: 0001104659-18-014887 · a4.xml · nonDerivative · entry 3 Farmer Joseph L · CIK 0001317757 · Sr.VP,Gen.Counsel & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,854 F2 · kind: This sale was effected pursuant to the terms of a 10b5-1 plan adopted by the reporting person and was made in order to pay the tax liability arising from the vesting of restricted stock units. F3 · price: The price reported is a weighted average. The shares were sold in multiple transactions at prices ranging from $54.38 to $54.87, inclusive. The reporting person undertakes to provide to TESARO, any security holder of TESARO, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein. Read SEC document |
| March 01, 2018 Filed Mar 5, 2018 17:26 UTC | TESARO, Inc. TSRO · Entity 160894 | GrantEmployee Stock Option (right to buy) · Derivative | 31,954 | $0.00 Strike: $55.84 | $0.00 |
DisclosureSEC source: 0001104659-18-014887 · a4.xml · derivative · entry 7 Farmer Joseph L · CIK 0001317757 · Sr.VP,Gen.Counsel & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,954 Underlying: Common Stock · 31,954 shares Expires 2028-03-01 F8 · derivative.exercise_date: The option vests in 48 equal monthly installments beginning on April 1, 2018. Read SEC document |
| March 01, 2018 Filed Mar 5, 2018 17:26 UTC | TESARO, Inc. TSRO · Entity 160894 | GrantRestricted Stock Units · Derivative | 18,182 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-18-014887 · a4.xml · derivative · entry 6 Farmer Joseph L · CIK 0001317757 · Sr.VP,Gen.Counsel & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,182 Underlying: Common Stock · 18,182 shares Expires not disclosed F4 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of TESARO common stock. F7 · derivative.exercise_date: The RSUs vest in four equal annual installments beginning on March 1, 2019. F7 · derivative.expiration_date: The RSUs vest in four equal annual installments beginning on March 1, 2019. Read SEC document |
| March 01, 2018 Filed Mar 5, 2018 17:26 UTC | TESARO, Inc. TSRO · Entity 160894 | Exercise / conversionRestricted Stock Units · Derivative | 1,483 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-18-014887 · a4.xml · derivative · entry 5 Farmer Joseph L · CIK 0001317757 · Sr.VP,Gen.Counsel & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,447 Underlying: Common Stock · 1,483 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of TESARO common stock. F6 · derivative.exercise_date: The RSUs were granted on March 1, 2017, and the remaining RSUs vest in three equal annual installments on each of March 1, 2019, 2020 and 2021. F6 · derivative.expiration_date: The RSUs were granted on March 1, 2017, and the remaining RSUs vest in three equal annual installments on each of March 1, 2019, 2020 and 2021. Read SEC document |
| March 01, 2018 Filed Mar 5, 2018 17:26 UTC | TESARO, Inc. TSRO · Entity 160894 | Exercise / conversionRestricted Stock Units · Derivative | 4,375 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-18-014887 · a4.xml · derivative · entry 4 Farmer Joseph L · CIK 0001317757 · Sr.VP,Gen.Counsel & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,750 Underlying: Common Stock · 4,375 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of TESARO common stock. F5 · derivative.exercise_date: The RSUs were granted on March 1, 2016, and the remaining RSUs vest in two equal annual installments on each of March 1, 2019 and 2020. F5 · derivative.expiration_date: The RSUs were granted on March 1, 2016, and the remaining RSUs vest in two equal annual installments on each of March 1, 2019 and 2020. Read SEC document |
| March 01, 2018 Filed Mar 5, 2018 17:26 UTC | TESARO, Inc. TSRO · Entity 160894 | Exercise / conversionCommon Stock | 1,483 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-18-014887 · a4.xml · nonDerivative · entry 2 Farmer Joseph L · CIK 0001317757 · Sr.VP,Gen.Counsel & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,488 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 01, 2018 Filed Mar 5, 2018 17:26 UTC | TESARO, Inc. TSRO · Entity 160894 | Exercise / conversionCommon Stock | 4,375 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-18-014887 · a4.xml · nonDerivative · entry 1 Farmer Joseph L · CIK 0001317757 · Sr.VP,Gen.Counsel & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,005 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 14 shares purchased pursuant to the TESARO, Inc. 2012 Employee Stock Purchase Plan in transactions that were exempt under Section 16b-3(c) and Section 16b-3(d). Read SEC document |
| August 01, 2017 Filed Aug 3, 2017 17:13 UTC | TESARO, Inc. TSRO · Entity 160894 | Exercise / conversionRestricted Stock Units · Derivative | 625 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-17-049349 · a4.xml · derivative · entry 2 Farmer Joseph L · CIK 0001317757 · Sr.VP, Gen.Counsel & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,875 Underlying: Common Stock · 625 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of TESARO common stock. F3 · derivative.exercise_date: The restricted stock units were granted on July 27, 2016 and vest in four equal annual installments beginning on August 1, 2017. F3 · derivative.expiration_date: The restricted stock units were granted on July 27, 2016 and vest in four equal annual installments beginning on August 1, 2017. Read SEC document |
| August 01, 2017 Filed Aug 3, 2017 17:13 UTC | TESARO, Inc. TSRO · Entity 160894 | Exercise / conversionCommon Stock | 625 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-17-049349 · a4.xml · nonDerivative · entry 1 Farmer Joseph L · CIK 0001317757 · Sr.VP, Gen.Counsel & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,616 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 172 shares purchased pursuant to the TESARO, Inc. 2012 Employee Stock Purchase Plan in transactions that were exempt under Section 16b-3(c) and Section 16b-3(d). Read SEC document |
| March 02, 2017 Filed Mar 3, 2017 17:16 UTC | TESARO, Inc. TSRO · Entity 160894 | SaleCommon Stock | 1,449 | $177.61 | $257,356.89 |
DisclosureSEC source: 0001104659-17-014108 · a4.xml · nonDerivative · entry 2 Farmer Joseph L · CIK 0001317757 · Sr VP,Gen. Counsel & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,819 F2 · kind: This sale was effected pursuant to the terms of a 10b5-1 plan adopted by the reporting person and was made in order to pay the tax liability arising from the vesting of restricted stock units. Read SEC document |
| March 01, 2017 Filed Mar 3, 2017 17:16 UTC | TESARO, Inc. TSRO · Entity 160894 | GrantEmployee Stock Option (right to buy) · Derivative | 10,782 | $0.00 Strike: $178.95 | $0.00 |
DisclosureSEC source: 0001104659-17-014108 · a4.xml · derivative · entry 5 Farmer Joseph L · CIK 0001317757 · Sr VP,Gen. Counsel & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,782 Underlying: Common Stock · 10,782 shares Expires 2027-03-01 F6 · derivative.exercise_date: The option vests in 48 equal monthly installments beginning on April 1, 2017. Read SEC document |
| March 01, 2017 Filed Mar 3, 2017 17:16 UTC | TESARO, Inc. TSRO · Entity 160894 | GrantRestricted Stock Units · Derivative | 5,930 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-17-014108 · a4.xml · derivative · entry 4 Farmer Joseph L · CIK 0001317757 · Sr VP,Gen. Counsel & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,930 Underlying: Common Stock · 5,930 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of TESARO common stock. F5 · derivative.exercise_date: The restricted stock units vest in four equal annual installments beginning on March 1, 2018. F5 · derivative.expiration_date: The restricted stock units vest in four equal annual installments beginning on March 1, 2018. Read SEC document |
| March 01, 2017 Filed Mar 3, 2017 17:16 UTC | TESARO, Inc. TSRO · Entity 160894 | Exercise / conversionRestricted Stock Units · Derivative | 4,375 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-17-014108 · a4.xml · derivative · entry 3 Farmer Joseph L · CIK 0001317757 · Sr VP,Gen. Counsel & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,125 Underlying: Common Stock · 4,375 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of TESARO common stock. F4 · derivative.exercise_date: The restricted stock units were granted on March 1, 2016 and vest in four equal annual installments beginning on March 1, 2017. F4 · derivative.expiration_date: The restricted stock units were granted on March 1, 2016 and vest in four equal annual installments beginning on March 1, 2017. Read SEC document |
| March 01, 2017 Filed Mar 3, 2017 17:16 UTC | TESARO, Inc. TSRO · Entity 160894 | Exercise / conversionCommon Stock | 4,375 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-17-014108 · a4.xml · nonDerivative · entry 1 Farmer Joseph L · CIK 0001317757 · Sr VP,Gen. Counsel & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,268 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 893 shares purchased pursuant to the TESARO, Inc. 2012 Employee Stock Purchase Plan in transactions that were exempt under Section 16b-3(c) and Section 16b-3(d). Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.